Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Paclitaxel 7 Cisplatin 6 pembrolizumab 5 Carboplatin 5 Bevacizumab 5 liposomal doxorubicin 3 Gemcitabine 3 trebananib 2 niraparib 2 interferon gamma-1b 2 dostarlimab 2 catumaxomab 2 atezolizumab 2 anlotinib 2 Topotecan 2 Radiotherapy, Intensity-Modulated 2 Ocoxin 2 Itraconazole 2 Injections 2 Hyperthermic Intraperitoneal Chemotherapy 2 Drug Therapy 2 Docetaxel 2 vosaroxin 1 vistusertib 1 pertuzumab 1 peginterferon alfa-2b 1 olaparib 1 nintedanib 1 lanreotide 1 epothilone B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × vistusertib × Gynecologic × Clear all

NCT02730923 2024-02-13

VICTORIA

Centre Leon Berard

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡